(579 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Virtual care, social media and mHealth for allergy management
-
Food allergy: new allergens on the block
-
Allergy to Kale
-
Risk assessment and active management of food allergy
-
Food allergy - the beginners guide
-
Elderly asthma
-
Novel cell based assays in allergy diagnostics
-
Asma e alergia em Angola
-
Tree nut allergy: path from national to global data
-
Over-the-counter allergy prevention weaning products
-
Nasal allergen challenge
-
The dilemma of food allergy additives
-
Living with food allergy
-
Molecular allergology in daily clinical practice
-
Evidence of immunotherapy on allergy prevention?
-
Asma e alergia em pandemia
-
Update on drug allergy
-
Prevention of food allergy: where are we now?
-
Management of adverse reactions to biologics
-
Tackling anaphylaxis
-
How do allergens sensitize?
-
Covid-19 in "Allergy" journal
-
Danger signs
-
Can group consultations work in allergy? Learning from rheumatology
-
Asthma management during the COVID-19 pandemics
-
Delabelling adults
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Adherence: A challenge for Immunotherapy
-
Immune modulation in local allergic rhinitis
-
An update on food allergy
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Air pollution and allergy: call for action!
-
An update on prevention of allergic diseases
-
Updates in [severe] asthma in adults
-
Food industry perspective
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Novel pharamacological targets
-
What do we learn from subgroup analyses in phase-III trials?
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
Social media and Allergies: how can we support our patients?
-
Hologenome and obesity
-
Update of the WAO anaphylaxis guidance
-
Epithelial cell barrier and allergic diseases
-
Big changes in asthma treatment : GINA 2019
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Diagnosis of insect venom allergy: back to basics
-
May contain traces… management in children with food allergies
-
Bronchial allergen challenge in the clinic
-
Management of CRS: Highlights of EPOS 2020
-
Management of CRS: Highlights of EPOS 2020
-
Skin care from birth for allergy prevention: results today
-
Understanding parent preferences for paediatric allergy services
-
Implementing component resolved diagnostics in allergy diagnosis
-
Differential diagnosis
-
Novel approaches of allergen immunotherapy
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
Can the birch pollen be more aggressive in the polluted environments?
-
A patient with an acute reaction: recognize, document and treat
-
AAAAI Practice Parameters
-
Neuroimmunology and allergy
-
Big data and cluster analysis: a real life perspective
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Potential biomarkers for diagnosis and treatment for CSU
-
The ‘allergy tool kit’ for the transition clinic
-
Telemedicine and Tele-health
-
Exercise: induced asthma and rhinitis
-
Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Treating allergic patients during the COVID-19 pandemic
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Role Viral reactivations
-
Bronchial allergen challenge in research
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
Impact of climate change on the immune system
-
Therapies for multiple-tree nut allergies
-
Global impact of the COVID-19 on the environment
-
How to improve outcomes
-
Early biomarkers for severe drug hypersensitivity reactions
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Impact of food allergy on household expenditures among Manitoba families
-
Late onset T2 asthma – a case study
-
New and clinically relevant contact allergens
-
Occupational respiratory allergy in food processing industries
-
Impact of climate change on asthma exacerbations
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Wild-fires, pollution, climate change and other threats
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
Developing an adolescent and young adult allergy service
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Implementation of telehealth in asthma management: trials and tribulations
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Vaccines for older adults: benefits and limitations
-
Oral food challenge versus biomarkers - are challenges still needed?
-
Structural biology of food allergens and cross reactivity
-
Viral infection and asthma
-
Airborne enzymes – New and re-emerging occupational hazards
-
Bronchiectasis and severe asthma
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC)
-
AI models
-
Urban green spaces - The exposure and allergenicity index
-
Cow's milk allergy guidelines promote over-diagnosis of milk allergy (Pro & Con Session: Con)
-
Cow's milk allergy guidelines promote over-diagnosis of milk allergy (Pro & Con Session: Pro)
-
Allergen immunotherapy for food allergy
-
Cow’s milk allergy can be monitored through the degree of competition between specific IgE and IgG
-
Oral food challenges thresholds for clinical reactions
-
Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
-
Predicting adverse reactions to biologicals
-
Big Data Analysis: MetabolomicsView Presentation
-
Eosinophilic fasciitis, an unusual presentation
-
Severe Asthma and COVID-19
-
Mechanisms of non IgE mediated food allergy
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Novel insight into development of allergic diseases
-
Alergia molecular na seleção de extratos para imunoterapia aos ácaros
-
Impacting quality of life with PALFORZIA
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Allergen immunotherapy for rhinitis phenotypes other than allergic rhinitis: mixed rhinitis and local allergic rhinitis
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Psychological support to peanut allergic children and their families
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Large spectrum response to Dupilumab in a patient with atopic multimorbidity
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Environmental epigenomics of allergy
-
Early life wheeze - risk factors for asthma in school age
-
Moisturisers for the primary prevention of food allergy
-
The basics of severe asthma - biomarkers
-
Is anaphylaxis really rare in children?
-
Collective advocacy for action on CRDs
-
MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
AIT, Biologicals and Covid vaccination
-
Targeted approaches for asthma
-
Sleep patterns and development of children with atopic dermatitis
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Insight from translational research on oral tolerance induction through breast milk
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
How to evaluate lung function? Hands-on plus lecture
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
New insights in urticaria mechanisms
-
Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience
-
Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study
-
Unusual presentations of contact dermatitis
-
Linking bovine milk components and their possible association with allergic diseases
-
Tezepelumab (anti-TSLP) in asthma
-
The engineering-medicine interface
-
Precision medicine in immunodeficiency
-
